Psilocybin dosing and adult neurogenesis

Psilocybin is a psychedelic compound that alters states of consciousness to allow free imagination and insightful creativity. Its ability to induce complex behavioral and psychological changes has led to its resurgence in psychedelic-enhanced psychotherapy. Despite positive clinical efficacy from a
handful of trials, an optimal (or even variable) treatment paradigm has yet to be established. Here, in partnership with Zylorion, a psychedelics-based biopharmaceutical company, we will test different doses and treatment paradigms, to be followed by testing in mice major depression models and
eventual clinical validation in individuals suffering from mental health conditions.

Faculty Supervisor:

Deborah Kurrasch

Student:

Partner:

Zylorion

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology

University:

University of Calgary

Program: